Cyclo Therapeutics, Inc.
CYTH
$0.7206
$0.00991.39%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -8.83M | -5.98M | -4.34M | -5.64M | -4.77M |
| Total Depreciation and Amortization | 2.20K | 2.20K | 2.20K | 4.80K | 4.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.74M | 984.70K | 277.20K | 310.70K | 202.00K |
| Change in Net Operating Assets | -1.10M | 1.15M | -2.12M | 1.03M | 523.30K |
| Cash from Operations | -8.19M | -3.85M | -6.18M | -4.29M | -4.04M |
| Capital Expenditure | -- | -- | -- | -2.40K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -2.40K | -- |
| Total Debt Issued | 8.00M | 2.00M | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | 2.90M | 5.00M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.40K | -25.20K | -69.30K | 8.84M | 0.00 |
| Cash from Financing | 8.00M | 1.97M | -69.30K | 11.74M | 5.00M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -193.80K | -1.87M | -6.25M | 7.44M | 960.30K |
